Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic Syndromes × Disulfides × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 11 Carcinoma, Non-Small-Cell Lung 8 Colorectal Neoplasms 4 Urinary Bladder Neoplasms 3 Nasopharyngeal Carcinoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Renal Cell 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Lymphoid Interstitial Pneumonia 2 Carcinoma, Hepatocellular 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Salivary Gland Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Prostatic Neoplasms 1 Papillary renal cell carcinoma, sporadic 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mycosis Fungoides 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Mouth Neoplasms 1 Mesothelioma, Malignant 1

Interventions

venetoclax 18 Azacitidine 17 fludarabine 11 fludarabine phosphate 8 Cyclophosphamide 8 Biopsy 8 Whole-Body Irradiation 7 Specimen Handling 7 Decitabine 7 decitabine and cedazuridine drug combination 6 Injections 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 Stem Cell Transplantation 5 Melphalan 5 Cytarabine 5 Mycophenolic Acid 4 Filgrastim 4 olutasidenib 3 X-Rays 3 Thiotepa 3 Mesna 3 Cyclosporins 3 Cyclosporine 3 Cladribine 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 ruxolitinib 2 posaconazole 2 pevonedistat 2 enasidenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡